# Neuralink Blindsight Vision-Implant Human Trials Imminent as Company Scales Production in 2026

> news · REPORTED · 2026-07-21

In mid-July 2026, Neuralink continued to advance its Blindsight implant toward first human trials, with Elon Musk having stated on X that first implantation would occur once regulatory approvals are finalized; the Blindsight device received FDA Breakthrough Device Designation in 2024 and is designed to restore vision by stimulating the visual cortex via a wirelessly connected camera. The company is also executing its stated 2026 goal of high-volume BCI device production and a streamlined, near-fully automated surgical procedure.

About Neuralink: Neuralink develops brain-computer interface implants designed to help people with paralysis control digital devices through thought and, with its Blindsight product, to restore vision in fully blind patients by directly stimulating the visual cortex.

- Company: Neuralink
- Sector: neurotech
- Primary source: https://www.statnews.com/2026/01/05/neuralink-brain-computer-interface-medical-device-vs-transhumanism/

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.